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We describe the CD4 lymphocyte count at HIV presentation in an HIV cohort from a rural district of India. The majority of
patients were diagnosed for their HIV-related symptoms, although a sizeable proportion of women were diagnosed because
of antenatal screening or for having an HIV-positive partner. Patients diagnosed of HIV for antenatal screening or having an
HIV-positive sexual partner had higher CD4 lymphocyte count than patients having tuberculosis or HIV-related symptoms. The
proportion of patients diagnosed with CD4 count <200 and <350 cells/mm3 were 46% and 68.7%, respectively, and these ﬁgures
did not change during the ﬁve years of the study. Factors associated with late presentations were male sex, older age, not having
a permanent house, and, in women, lower education and being a widow or separated. With the implementation of 2010 WHO
guidelines,thenumberofnewlydiagnosedpatientswhowillrequireHIVtreatmentwillincrease13.8%.IftheCD4countthreshold
for initiating HIV treatment is increased from 350 to 500 cells/mm3, the number of patients in need of treatment would increase
15.7%. Therefore, new strategies for avoiding HIV late presentation are urgently needed in developing countries.
1.Introduction
International HIV guidelines for the use of antiretroviral
therapy (ART) in adults areshifting towards earlier initiation
of HIV treatment [1–3]. Late initiation of ART is associated
with higher risk of death and opportunistic infections as
well as poorer response to treatment [4, 5]. However,
patients who are diagnosed when their CD4 lymphocyte
count is low are not able to get the beneﬁts of an early
ART initiation. From the public health point of view, these
patients have a longer period of undiagnosed HIV infection.
Late presentation of HIV delays patients from receiving
education for avoiding the infection to others and precludes
them from receiving ART, which can reduce their HIV viral
load and, therefore, lowering the risk of HIV transmission to
others.
In Europe and North America, approximately 30 to 35%
ofpatients haveCD4 lymphocytecountbelow 200cells/mm3
at HIV diagnosis [6, 7]. Despite having more than 90% of
the world burden of people living with HIV [8], information
about the immunological situation at HIV diagnosis of
patients from developing countries is scarce [9].
The aim of this study is to describe the CD4 lymphocyte
count at HIV presentation in patients from a rural district
of India and to investigate factors associated with late
presentation [10]. We have also performed a simulation of
how many people will require ART in this setting utilizing2 Interdisciplinary Perspectives on Infectious Diseases
Table 1: Reasons for HIV diagnosis.
Reason for HIV testing N %
HIV-related symptoms 3857 62.06
HIV+ partner 1314 21.14
Pregnancy screening 348 5.60
Voluntary 189 3.04
Presurgery 54 0.87
Tuberculosis 53 0.85
Sexually transmitted infection 31 0.50
Blood donation 6 0.10
Vertical transmission 4 0.06
Unknown 359 5.78
Total 6215 100
Men Women
Symptoms
Unknown
Pregnancy
Voluntary
Others
Symptoms
Unknown
Pregnancy
Voluntary
Others
HIV + partner HIV + partner
Figure 1: Reasons for HIV diagnosis in women and men.
threediﬀerentCD4lymphocytecountthresholdsforstarting
ART according to current guidelines [1–3, 11].
2. Patientsand Methods
With 2.4 millions of HIV-infected people, India carries the
largest population of people living with HIV in Asia and
is the third country of the world in terms of HIV-infected
people [12]. Andhra Pradesh is the state with highest burden
of HIV in India, and HIV is transmitted mainly through
heterosexual contacts [13]. Anantapur is a district with
74.7% of rural population situated in the south border of
Andhra Pradesh [14]. Rural Development Trust (RDT) is
a nongovernmental organization who has three hospitals
in the district. In these hospitals, medical care of HIV-
infected people is given free of cost, including medicines and
consultation or admission charges. In Bathalapalli Hospital,
the biggest hospital of RDT, outpatient clinics and 71 beds
are allocated exclusively for HIV-infected patients where
they can receive free specialized medical care for their
opportunistic infections or other heath problems. Hence,
most of people living with HIV in the district have visited
our hospitals. We work in close collaboration with the ART
Centres and Integrated Counselling and Testing Centres
from the governmental Andhra Pradesh State AIDS Control
Society.
The Vicente Ferrer HIV Cohort Study (VFHCS) is an
open cohort study of all HIV-infected patients who have
been visited in RDT hospitals since June 2006. Data from
patients were collected prospectively since September 2009
and retrospectively from June 2006 to September 2009.
Details of route of transmission, reason for HIV testing,
and sociodemographic data are collected at enrolment. The
VFHCS has been approved by the ethical committee of the
RDT Institutional Review Board.
All patients from the VFHCS living in the district of
Anantapur, aged above 15 years, who were diagnosed of
HIV between June 2006 and March 2011 and who had at
least one determination of CD4 lymphocyte count before
starting ART were included in the study. Measurement of
CD4 lymphocyte count was performed using ﬂow cytometry
(Cyﬂow SL, Partec, Munster, Germany). HIV diagnosis was
performed following the guidelines of the National AIDS
Control Organization of India [15], and counselling was
given before performing the HIV test and after knowing the
result of the test.
Patients whose ﬁrst CD4 lymphocyte count was below
350cells/mm3 were deﬁned as late presenters following
current recommendations [10]. Logistic regression was used
for the multivariable analysis of factors associated with
late presentation of HIV infection using Stata Statistical
Software (Stata Corporation, Release 11, College Station,
TX, USA) [16]. Missing values were imputed using multiple
imputations by chained equation [17]. Conﬁdence intervals
(CIs) for the diﬀerence in the proportion of patients who
will require HIV treatment using three diﬀerent CD4 count
thresholds were calculated using the Agresti-Caﬀop r o c e -
dure. This method is considered to have better performance
than the traditional Wald method for calculating the CIs for
the diﬀerence between two independent proportions [18].
Because CD4 lymphocyte determinations are performed
approximately every six months, life graphs for the propor-
tionofpatientswhowouldrequireinitiationofantiretroviral
treatment according to three diﬀerent CD4 lymphocyte
count thresholds were calculated at 6-month intervals.
3. Results
Out of 7905 HIV-positive patients diagnosed of HIV during
the period of the study, 6215 (78.6%) had at least one CD4
lymphocyte count determination before starting ART and
were included in the study. Reasons for HIV testing are
presented in Table 1. Most of the patients were diagnosed
for having HIV-related symptoms. Diﬀerences in the reasons
for HIV diagnosis between men and women are shown in
Figure 1. In women, the proportion of patients diagnosed
for having an HIV-positive partner was higher than in men
(P<0.001). Median and interquartile range (IQR) of CD4
lymphocyte count at HIV presentation was 218 (IQR, 108–
402).MedianCD4lymphocytecountatpresentationwas287
(IQR, 138–466) for women and 180 (IQR, 91–331) for men
(P<0.001). Relation between CD4 lymphocyte count andInterdisciplinary Perspectives on Infectious Diseases 3
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Figure 2: Description of CD4 lymphocyte count by reason for HIV testing in descending order from right to left. Boxes represent median
and 25–75 percentiles. Whiskers represent 5 and 95 percentiles. ∗STI: sexually transmitted infection.
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Figure 3:MedianandinterquartilerangeofCD4lymphocytecount
at HIV presentation by calendar year of presentation.
reason for HIV testing are presented in Figure 2. We did not
observe gender diﬀerences in CD4 lymphocyte counts when
stratifying by reason for HIV testing.
Median and IQR of CD4 lymphocyte count at presenta-
tion in each calendar year during the period of the study
are shown in Figure 3. The ﬁgure shows that the CD4
lymphocyte count at HIV presentation has remained stable
during the ﬁve years of the study.
Multivariable analysis of factors associated with late
presentation is described in Table 2. Factors associated with
late HIV presentation were older age and not having a per-
manent house. No diﬀerence was seen among communities,
monthly income, living near a city, route of transmission, or
consuming alcohol. In women, late presentation was more
common among those with lower education or who were
w i d o wo rs e p a r a t e d .A m o n gm e n ,w e a v e r sw e r el e s sl i k e l yt o
have late presentation.
Proportions of patients for four CD4 lymphocyte count
thresholds at presentation are presented in Table 3. Approx-
imately, two-thirds of patients presented with a CD4 lym-
phocyte count below 350cells/mm3 and 46% with CD4
lymphocyte count below 200cells/mm3. Figure 4 represents
the cumulative incidence of newly diagnosed patients who
will require ART according to three diﬀerent thresholds for
starting HIV treatment after 0, 6, 12, 18, 24, 30, and 36
months since the ﬁrst determination of CD4 lymphocyte
count. For constructing this graph, all CD4 lymphocyte
count determinations before starting ART were taken into
account. Current National AIDS Control Organization of4 Interdisciplinary Perspectives on Infectious Diseases
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Figure 4: Cumulative incidence of patients who will require antiretroviral treatment according to three diﬀerent thresholds for initiating
HIV treatment after 0, 6, 12, 18, 24, 30 and 36 months since the ﬁrst determination of CD4 lymphocyte count. ∗ART: antiretroviral therapy.
IndiaguidelinesforHIVtreatmentrecommendstartingART
when the CD4 lymphocyte count is below 250cells/mm3
following previous WHO recommendation for initiating
ART before patients had CD4 lymphocyte count below
200cells/mm3 [11]. With the 2010 World Health Organi-
zation (WHO) guidelines, the threshold for starting HIV
treatment has been increased to 350 CD4cells/mm3 [3].
According to our data, the implementation of 2010 WHO
guidelines will increase the number of patients who will
need antiretroviral treatment after the ﬁrst determination
of CD4 lymphocyte count in 13.8% (95% CI 12.1–15.5).
If the threshold is increased from 350 to 500 CD4 cells as
is contemplated in other guidelines [1, 2], the number of
patients who will require treatment would increase 15.7%
(95% CI 14.2–17.1). These diﬀerences are progressively
reduced over time.
4. Discussion
In this study we found that an important proportion of
HIV-infected patients presented with low CD4 lymphocyte
count. In another study also performed in India in an urban
reference hospital of New Delhi, the proportion of patients
who presented with CD4 cell count below 200cells/mm3
was lower than in our study [19]. This may reﬂect a later
presentation of HIV in rural settings compared to urban
settings in India. When comparing our results with other
study performed in Nigeria, CD4 count at presentation was
lower in African women, but diﬀerences were not important
between Nigerian and Indian men [20]. Considering the
three studies, the proportion of patients who present with
CD4 lymphocyte count below 200cells/mm3 in developing
countriescanbeprobablybetween40and50%.Morestudies
addressing late presentations of HIV in the developing world
areurgentlyneeded.WemustrememberthateﬀectiveARTis
oneofthemosteﬀectivemeasurestoreducethetransmission
of HIV [21]. Increasing the threshold of CD4 lymphocyte
count for starting ART is important, but it should be
accompanied by the implementation of new strategies for
achieving earlier diagnosis of HIV. As seen in Figure 3,
the CD4 lymphocyte count at presentation remained stable
during the period of the study, indicating that if we do not
change the way HIV is diagnosed, we will continue to face
the problem of late presentation of HIV in India.
The results of this study show the relation between the
CD4 lymphocyte count at presentation and the reason for
HIVtesting.Thisobservationisessentialfordesigningpublic
health interventions orientated to achieve early detection of
HIV infection. In the majority of patients, the HIV diagnosis
was made because a health worker suspected that their
symptoms could be explained by an HIV infection, leading
to a late diagnosis of HIV. When the reason for testing
was related to having risk factors for HIV in asymptomatic
patients, like having sexually transmitted diseases or an HIV-
positive partner, CD4 lymphocyte count at presentation
was higher than patients with tuberculosis or HIV-related
symptoms (P<0.001). The best results in terms of
early diagnosis were seen in the screening of pregnant
women. However, strategies that involve massive HIV testing
to the population are not feasible in a highly populated
country with relatively low prevalence of HIV such as India.
Interventions that involve facilitating HIV testing in all types
of health facilities, including small and rural clinics, for
patients who have risk factors for HIV infection can be a
better cost-eﬀective option. It is important to generalize the
use of the HIV testing in India. Integrated Counselling and
Testing Centres are able to provide good pre- and posttest
counselling, but patients are reluctant to attend them due to
the problem of HIV-associated stigma in India.
We found important diﬀerences in factors associated
with late HIV presentation between women and men.
In women, late presentation was associated with lower
education level and being widow, separated, or divorced
indicating the diﬃculties of reaching the health care system
for women in the Indian rural setting. In an urban tertiaryInterdisciplinary Perspectives on Infectious Diseases 5
Table 2: Factors associated with late HIV presentation stratiﬁed by gender.
Women Men
CD4 count CD4 count <350/mm3 CD4 count CD4 count <350/mm3
Median (IQR) Proportion (%) aOR 95% CI Median (IQR) Proportion (%) aOR 95% CI
Age (years)
15 to 24 373 (223–548) 464/999 (46.4) 0.58∗∗∗ (0.48–0.71) 249 (128–414) 226/336 (67.3) 0.71∗ (0.54–0.94)
25 to 34 271 (133–447) 744/1213 (61.3) 1 Reference 185 (94–353) 1122/1512 (74.2) 1 Reference
35 to 44 190 (95–355) 348/473 (73.6) 1.64∗∗∗ (1.26–2.12) 159 (79–287) 804/999 (80.5) 1.47∗∗∗ (1.20–1.80)
≥45 160 (84–293) 156/191 (81.7) 2.48∗∗∗ (1.62–3.79) 161 (87–302) 406/492 (82.5) 1.67∗∗∗ (1.26–2.20)
Marital status
Single 217 (105–429) 18/27 (66.7) 1.73 (0.62–4.78) 197 (105–353) 241/328 (73.5) 1.09 (0.81–1.48)
Married 315 (162–510) 941/1705 (55.2) 1 Reference 180 (91–332) 1987/2597 (76.5) 1 Reference
Separated-divorced 225 (111–435) 134/200 (67) 1.44∗ (1.01–2.05) 139 (82–293) 110/134 (82.1) 1.41 (0.88–2.25)
Widow 241 (118–408) 581/881 (65.9) 1.24∗ (1.01–1.53) 156 (80–280) 161/202 (79.7) 1 (0.69–1.46)
Education
Higher 355 (166–525) 25/54 (46.3) 0.50∗ (0.26–0.96) 212 (112–368) 119/167 (71.3) 0.86 (0.57–1.29)
Secondary 367 (197–546) 264/567 (46.6) 0.58∗∗∗ (0.46–0.73) 189 (92–343) 804/1065 (75.5) 1.02 (0.83–1.26)
Primary 325 (170–532) 166/307 (54.1) 0.79 (0.59–1.04) 171 (94–315) 504/638 (79) 1.14 (0.90–1.45)
No education 253 (120–428) 1219/1884 (64.7) 1 Reference 168 (88–325) 1077/1397 (77.1) 1 Reference
Community
Other castes 294 (134–477) 378/641 (59) 0.93 (0.75–1.16) 175 (87–340) 674/887 (76) 0.93 (0.76–1.14)
Backward castes 290 (140–461) 842/1414 (59.5) 1 Reference 184 (95–330) 1203/1573 (76.5) 1 Reference
Scheduled castes 266 (126–452) 373/603 (61.9) 1.06 (0.85–1.33) 174 (85–313) 532/672 (79.2) 1.14 (0.90–1.43)
Scheduled tribes 303 (168–498) 119/218 (54.6) 0.77 (0.56–1.07) 175 (104–379) 149/207 (72) 0.77 (0.55–1.09)
House type
Owned 295 (150–470) 773/1321 (58.5) 1 Reference 185 (101–340) 1166/1536 (75.9) 1 Reference
Rented 314 (167–473) 513/925 (55.5) 0.91 (0.75–1.10) 197 (101–361) 673/910 (74) 0.98 (0.80–1.20)
No house 200 (90–402) 202/292 (69.2) 1.50∗ (1.10–2.04) 134 (67–267) 323/383 (84.3) 1.60∗∗ (1.18–2.17)
Other 274 (118–454) 59/97 (60.8) 1.05 (0.67–1.66) 135 (80–294) 159/201 (79.1) 1.39 (0.96–2.02)
Monthly income (INRa)
<1000 281 (140–460) 715/1204 (59.4) 1 Reference 178 (90–325) 942/1223 (77) 1 Reference
1001 to 2000 287 (154–432) 204/339 (60.2) 0.98 (0.74–1.30) 182 (97–325) 547/705 (77.6) 1.12 (0.89–1.42)
2001 to 3000 270 (119–443) 71/111 (64) 1.25 (0.79–1.96) 182 (92–369) 236/323 (73.1) 0.92 (0.69–1.24)
>3000 303 (148–458) 76/135 (56.3) 1 (0.65–1.54) 183 (89–353) 529/707 (74.8) 0.93 (0.74–1.19)
Not applicable 297 (144–493) 489/839 (58.3) 1.13 (0.86–1.48) 160 (89–299) 224/280 (80) 1.18 (0.82–1.69)
Occupation
Unskilled labourer 257 (122–435) 932/1472 (63.3) 1 Reference 170 (87–323) 947/1219 (77.7) 1 Reference
Driver 180 (93–330) 307/406 (75.6) 1.05 (0.79–1.40)
Farmer 379 (211–536) 40/84 (47.6) 0.73 (0.44–1.21) 161 (86–304) 362/454 (79.7) 1.19 (0.89–1.59)
Health worker 304 (177–551) 22/41 (53.7) 1.11 (0.54–2.30) 250 (127–500) 5/10 (50) 0.4 (0.11–1.49)
Housekeeper 336 (176–521) 398/752 (52.9) 0.91 (0.69–1.21) 388 (220–594) 2/5 (40) 0.18 (0.03–1.18)
Weaver 319 (226–488) 16/30 (53.3) 0.91 (0.40–2.09) 272 (118–426) 42/70 (60) 0.52∗ (0.31–0.87)
Others 273 (140–463) 220/367 (59.9) 1.11 (0.85–1.45) 193 (98–343) 789/1049 (75.2) 1 (0.80–1.24)
Unemployed 168 (100–356) 40/57 (70.2) 0.99 (0.50–1.98) 131 (82–261) 49/56 (87.5) 2.13 (0.89–5.12)
Living near a cityb
No 286 (136–458) 966/1610 (60) 1 Reference 171 (87–318) 1466/1874 (78.2) 1 Reference
Yes 286 (138–470) 746/1266 (58.9) 1 (0.84–1.19) 189 (97–353) 1092/1465 (74.5) 0.87 (0.73–1.03)
Route of transmission
Heterosexual 291 (140–468) 1443/2453 (58.8) 1 Reference 178 (90–326) 2446/3174 (77.1) 1 Reference
Blood transfusion 263 (129–479) 43/66 (65.2) 1.15 (0.61–2.16) 191 (92–315) 17/22 (77.3) 0.93 (0.33–2.60)6 Interdisciplinary Perspectives on Infectious Diseases
Table 2: Continued.
Women Men
CD4 count CD4 count <350/mm3 CD4 count CD4 count <350/mm3
Median (IQR) Proportion (%) aOR 95% CI Median (IQR) Proportion (%) aOR 95% CI
Homosexual 386 (313–406) 2/5 (40) 0.36 (0.05–2.47)
Others 250 (139–363) 14/21 (66.7) 1.48 (0.42–5.23) 214 (102–387) 17/24 (70.8) 0.7 (0.27–1.83)
Alcohol consumption
Yes 282 (153–431) 15/20 (75) 1.58 (0.41–6.07) 173 (89–324) 1592/2064 (77.1) 0.99 (0.83–1.19)
Never 288 (140–462) 1579/2667 (59.2) 1 Reference 192 (95–345) 911/1200 (75.9) 1 Reference
aIndian Rupees (approximately 1$ = 46 INR in September 2011).
bpopulation >100,000 people.
∗∗∗P<0.001, ∗∗P<0.01, ∗P<0.05.
Table 3: Proportions and Wilson 95% conﬁdence intervals for four diﬀerent CD4 cell count thresholds at HIV presentation.
Total (n = 6215) Women (n = 2876) Men (n = 3339)
CD4cells/mm3 Proportion 95% CI Proportion 95% CI Proportion 95% CI
<50 8.9% (8.2–9.7) 6.3% (5.5–7.3) 11.2% (10.1–12.3)
<200 46.0% (44.7–47.2) 35.7% (34.0–37.5) 54.8% (53.1–56.5)
<350 68.7% (67.5–69.8) 59.5% (57.7–61.3) 76.6% (75.1–78.0)
<500 84.4% (83.4–85.2) 78.4% (76.9–79.9) 89.5% (88.4–90.5)
hospital care setting [19], late presentation was seen to be
associated with male sex and older age.
With the implementation of 2010 WHO ART guidelines
in India, more than two-thirds of newly diagnosed HIV-
infected patients will require immediate initiation of ART.
This can be challenging because side eﬀects of ART are
common and many of these patients will be asymptomatic
prior to ART initiation. It is essential to provide intensive
counselling about the possible side eﬀects of the drug and
the long-term beneﬁts of the medication to avoid patients to
be lost during followup. In terms of cost of antiretrovirals
and not taking into account the economical beneﬁts of an
earlierinitiationofART[22,23],thenumberofpatientswho
will require ART will increase by around 14%. However, if
we observe Figure 4, this diﬀerence decreases over the time
reaching approximately 9% after three years. Also looking
at Figure 4, increasing the threshold for ART initiation from
250 to 350cells/mm3 and from 350 to 500cells/mm3,w ea r e
actually bringing forward approximately 18 and 27 months,
respectively, the initiation of ART in the population.
The study has some drawbacks. When estimating the
antiretroviral need of the population, we have not taken
into consideration clinical data from the patients. Some of
the patients with CD4 lymphocyte count between 250 and
350cells/mm3 may have required initiation of ART because
of their HIV-related symptoms. Also, information about the
reason for HIV testing and route of transmission was per-
formed through direct questioning to the patients. Patients
may have been reluctant to answer when interrogated about
sexuallytransmitted diseasesorhomosexualcontactsleading
to an underrepresentation of these factors in the study. In
addition, data from patients who did not attend our clinics
after September 2009 were collected retrospectively using
the clinical notes of the patients, so some of these data were
missed if no information was present in the clinical notes.
5. Conclusions
The results of this study can have important implication for
designingpublichealthinterventionindevelopingcountries.
The proportion of HIV late presenters in this Indian rural
setting, which has remained stable in the last ﬁve years, was
higher than the proportion of late presenters reported in
western countries. Most of the patients are diagnosed of
HIVwhentheyexperienceHIV-relatedsymptoms,especially
men.NewstrategiesforreducingthelatepresentationofHIV
should focus on screening of patients with risk factors for
havingHIVinfectionwhentheyarestillasymptomatic.With
the implementation of 2010 WHO guidelines for ART, two-
thirds of HIV patients will require immediate initiation of
ART after the ﬁrst determination of CD4 lymphocyte count.
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